Liquid pharmaceutical compositions

Details Liquid pharmaceutical compositions Liquid pharmaceutical compositions

2007-08-14

2007-08-14

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

Reexamination Certificate

active

10602215

ABSTRACT:
A liquid pharmaceutical composition of a GABA analog comprising at least one polyhydric alcohol containing 2 to 6 carbon atoms having a pH of about 5.5 to about 7.0 and additionally a two-component liquid pharmaceutical composition comprising a first component comprising a powder mixture comprising a GABA analog and a solid polyhydric alcohol, and a second component comprising a liquid base are described, as well as methods to prepare the compositions and a method for treating cerebral diseases, including epilepsy, faintness attacks, hypokinesia and cranial traumas, neurodegenerative disorders, depression, mania and bipolar disorders, anxiety, panic, inflammation, renal colic, insomnia, gastrointestinal damage, incontinence, pain, including neuropathic pain, muscular pain, skeletal pain, and migraine using a therapeutically effective amount of the pharmaceutical compositions.

REFERENCES:
patent: 0652012 (1995-05-01), None
patent: 9959573 (1999-11-01), None
patent: 0243762 (2002-06-01), None
Zour et al. Stability Studies of Gabapentin in Aqueous Solutions. Pharmaceutical Research, 1992, v. 9, pp. 595-600.

Affiliated with

Also associated with

Rating

Liquid pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3889128